Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy

References

Page 1

	Year	Citations
Cancer statistics, 2017 Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal CA A Cancer Journal for Clinicians Epidemiology Of CancerPopulation Health SciencesCancer RegistrationUnited StatesCancer Risk Factors	2017	14.9K
A Proportional Hazards Model for the Subdistribution of a Competing Risk Jason P. Fine Journal of the American Statistical Association PrognosisRare Event EstimationRisk MetricRisk AnalysisEmerging Risk	1999	13.2K
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies Peter C. Austin Multivariate Behavioral Research Treatment EffectQuasi-experimentCausal InferencePreventive MedicineBias	2011	11.2K
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer The Lancet Gastrointestinal OncologyMedicinePharmacologyColorectal CancerAnti-cancer Agent	1995	1.1K
Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent, Journal of Clinical Oncology	2004	1K
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials Daniel J. Sargent, Alberto Sobrero, Axel Grothey, Journal of Clinical Oncology	2009	668
Cancer burden in the aged: an epidemiologic and demographic overview. Rosemary Yancik PubMed AgingPuerto RicoEpidemiology Of CancerCancer RegistrationGeriatric Medicine	1997	560
Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer Deborah Schrag, Laura D. Cramer, Peter B. Bach, JNCI Journal of the National Cancer Institute	2001	486
Cancer burden in the aged Rosemary Yancik Cancer Geriatric PsychiatryAgingPuerto RicoEpidemiology Of CancerGeriatric Medicine	1997	467
Regression modeling of competing risk using R: an in depth guide for clinicians Luca Scrucca, Annalisa Santucci, Franco Aversa Bone Marrow Transplantation Preventive MedicineRisk Model ValidationDisease Risk AssessmentMedicineRisk Management	2010	465

Page 1